Introduction

Counterfeit medicines are a major global public health threat — they can contain incorrect ingredients, wrong dosages, or harmful substances, and are deliberately designed to mimic genuine products. This risk endangers patient safety and undermines trust in healthcare systems. In response, robust pharmaceutical serialization and medicine verification technologies are now becoming essential. Scan Plus is designed to protect the pharmaceutical supply chain from counterfeit medicines while supporting regulatory compliance in the UK and Europe.

What Are Counterfeit Medicines?

Counterfeit medicines is also referred to as falsified medicines, are pharmaceutical products that deliberately misrepresent their identity, composition, or source. They may:

  • Contain incorrect, insufficient, or excessive active ingredients
  • Include harmful contaminants or unknown substances
  • Be repackaged, relabelled, or altered fraudulently
  • Enter legitimate supply chains through weak control points or poor oversight

These products can appear visually identical to authentic medicines, making detection difficult without structured medicine verification systems and secure barcode verification for medicines.

Why Counterfeit Medicines Are a Serious Public Health Threat

The presence of counterfeit medicines affects both patient safety and the integrity of healthcare systems.

1. Treatment Failure

Incorrect or absent active ingredients can lead to therapeutic failure.

2. Toxicity and Adverse Reactions

Unknown substances may cause severe side effects.

3. Antimicrobial Resistance

Substandard doses contribute to drug resistance.

4. Loss of Public Trust

Weak supply chain transparency erodes confidence in healthcare providers and pharmaceutical brands.

For regulators and manufacturers alike, preventing counterfeit medicines is not only a compliance requirement, but it is a core patient protection responsibility.

How Serialization and Track & Trace Prevent Counterfeit Drugs

Modern anti-counterfeit pharmaceutical solutions rely on serialization and digital traceability systems.

Pharmaceutical Serialization

Pharmaceutical serialization assigns a unique identifier to each medicine pack. This identifier is typically encoded in a 2D Data Matrix barcode and includes:

  • Product code
  • Serial number
  • Batch number
  • Expiry date

Serialization ensures that every pack can be individually identified and tracked throughout its lifecycle.

Track and Trace Systems for Pharma

A compliant track and trace system for pharma enables:

  • Recording and management of serial numbers at the packaging level
  • Secure data exchange with national and regional verification repositories
  • Real-time authentication at key supply chain points, such as wholesalers and pharmacies.
  • Decommissioning of packs at the point of dispensing or export

When integrated correctly, anti-counterfeit medicine technology ensures that a product can be verified before it reaches the patient.

Regulatory Frameworks Driving Anti-Counterfeit Compliance

EU Falsified Medicines Directive (FMD)

The EU Falsified Medicines Directive (FMD) introduces harmonised measures to prevent falsified medicines from entering the legal supply chain. Under this framework:

  • Most prescription medicines must carry a unique identifier in a 2D Data Matrix and a human-readable format.
  • Tamper-evident features are required on outer packaging.
  • Verification and decommissioning must occur at the point of supply to the patient in the EU (and in Northern Ireland).

The European Medicines Agency (EMA) oversees implementation in collaboration with national authorities.

UK Compliance Expectations

In the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) sets regulatory expectations around medicine safety, falsified medicines, and supply chain traceability. While post-Brexit adjustments have changed how EU FMD systems apply, core safety principles remain focused on preventing falsified medicines and ensuring reliable drug traceability.

Pharmaceutical companies operating in or exporting to the UK and EU must maintain structured EU FMD compliance support processes and validated serialization workflows.

How Scan Plus Supports Pharma Companies

Scan Plus, developed by Topia Pharma Intelligence, provides structured, compliance-focused pharmaceutical serialization solutions and verification support aligned with regulatory requirements. Scan Plus helps pharmaceutical organisations by enabling practical, implementation‑ready serialization and verification workflows that integrate with existing packaging and IT environments.

1. Serialization Workflow Support

Scan Plus assists manufacturers and supply chain stakeholders with serialization processes that enable:

  • Generation and management of unique serial numbers
  • Integration of 2D barcode systems
  • Data exchange alignment with verification repositories

These structured track-and-trace workflows improve transparency and help organisations maintain compliance with safety-feature regulations where applicable

2. Medicine Verification Systems

Scan Plus supports the implementation of medicine verification systems that allow secure authentication of pharmaceutical products before supply or dispensing. This includes:

  • Barcode verification for medicines using 2D Data Matrix Codes
  • Compliance validation workflows
  • Data management aligned with EU FMD and national verification expectations

3. Anti-Counterfeit Medicine Technology

Through structured verification and traceability support, Scan Plus contributes to the adoption of practical anti-counterfeit medicine technology that strengthens supply chain controls without disrupting operational efficiency.

4. EU FMD Compliance Support

Scan Plus helps organisations design and maintain EU FMD-aligned serialization and verification processes, from serial number management to upload and alert handling workflows. Rather than relying on broad or exaggerated claims, Scan Plus focuses on practical implementation, compliance alignment, and operational readiness within real pharmaceutical environments.

Strengthening Supply Chain Transparency

Effective drug traceability requires more than software alone requires:

  • Standardised processes across manufacturing, packaging, and distribution
  • Secure data handling and robust integration with verification systems
  • Regulatory awareness and up-to-date understanding of safety-feature obligations
  • Cross-functional coordination between quality, regulatory, IT, and supply chain teams

By supporting serialization and verification workflows, Scan Plus helps manufacturers, MAHs, CMOs, and distributors reduce the risk of counterfeit medicines entering legitimate distribution channels.

In a regulatory landscape that demands accountability and patient protection, structured serialization and verification systems are no longer optional — they are essential.

Conclusion

Counterfeit medicines pose a serious and measurable threat to public health and healthcare system integrity worldwide. Regulators across the UK and Europe have responded with structured frameworks built around pharmaceutical serialization, medicine verification, and secure track and trace systems.

Scan Plus supports pharmaceutical organisations in implementing compliant anti-counterfeit pharmaceutical solutions, strengthening drug traceability, and aligning serialization workflows with regulatory expectations.

By improving verification processes and reinforcing supply chain controls, Scan Plus contributes to a safer, more transparent pharmaceutical distribution ecosystem in which patient safety remains the highest priority.

Frequently Asked Questions (FAQs)

Pharmaceutical serialization is the process of assigning a unique identifier to each medicine pack to enable tracking and verification across the supply chain. It is a core requirement under the EU FMD framework.

Track and trace systems for pharma record and verify unique serial numbers at key stages of the supply chain, enabling suspect packs to be flagged and removed before reaching patients

The EU FMD is legislation designed to prevent falsified medicines from entering the legal supply chain by requiring serialization, tamper-evident packaging, and verification at dispensing points.

Manufacturers and supply chain partners implement medicine verification systems that allow scanning and authentication of serialized barcodes at various checkpoints, including wholesalers and pharmacies.

Scan Plus provides pharmaceutical serialization solutions, structured track and trace systems for pharma, and EU FMD compliance support that help organisations implement secure verification and traceability workflows aligned with regulatory expectations.

References